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Abstract 
Primary hepatocyte cultures are now considered as convenient models for in vitro analyzing 
liver drug transport. However, if primary human and rat hepatocytes have been well-
characterized with respect to drug transporter expression and regulation, much less is known 
for primary mouse hepatocytes. The present study was therefore designed to gain insights 
about this point. The profile of sinusoidal and canalicular drug transporter mRNA expression 
in short time (4 h)-cultured mouse hepatocytes was found to be highly correlated with that of 
freshly isolated hepatocytes; by contrast, those of counterparts cultured for a longer time 
(until 4 days) either in monolayer configurations on plastic or collagen or in sandwich 
configuration with matrigel were profoundly altered: uptake drug transporters such as Oct1, 
Oatps and Oat2 were thus down-regulated, whereas most of efflux transporters such as 
Mdr1a/b, Mrp3, Mrp4 and Bcrp were induced. Moreover, short time-cultured hepatocytes 
exhibited the highest levels of sinusoidal influx transporter activities. Transporter-mediated 
drug secretion into canalicular networks was however only observed in sandwich-cultured 
hepatocytes. Mouse hepatocytes cultured either in monolayer or sandwich configurations 
were finally shown to exhibit up-regulation of referent transporters in response to exposure to 
prototypical activators of the drug sensing receptors pregnane X receptor, aryl hydrocarbon 
receptor or constitutive androstane receptor. Taken together, these data demonstrate the 
feasibility of using primary mouse hepatocytes for investigating potential interactions of 
xenobiotics with hepatic transporter activity or regulation, provided that adequate culture 
conditions are retained. 
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1. Introduction 
Hepatic drug transporters belonging to the solute carrier (SLC) or the ATP-binding cassette 
(ABC) transporter superfamilies are involved in hepato-biliary secretion of drugs and drug-
drug interactions (Giacomini et al., 2010). They are located at the sinusoidal or canalicular 
pole of hepatocytes (Funk, 2008; Hirouchi et al., 2009) (See Fig. 1 for a schematic overview 
of drug transporter expression by mouse hepatocytes). Putative interactions of some hepatic 
transporters with new molecular entities developed by pharmaceutical companies have now to 
be characterized (Giacomini et al., 2010; Zhang et al., 2008). For this purpose, primary 
hepatocyte cultures have emerged as a valuable and useful tool (Ghibellini et al., 2006; Sahi et 
al., 2010; Soars et al., 2007).  
 Cultured hepatocytes can be used either in a monolayer standard configuration, i.e., 
hepatocytes plated on plastic dishes or collagen-coated dishes, or in a sandwich configuration, 
i.e., hepatocytes plated on collagen-coated dishes and overlaid with a second layer of collagen 
or matrigel (LeCluyse, 2001). These two configurations have been successfully retained to 
study drug transporter activity and regulation (Jigorel et al., 2006; Swift et al., 2010). Rat 
hepatocytes cultured in conventional monolayer conditions however fail to display bile 
canalicular structures and show a marked down-regulation of sinusoidal influx drug 
transporters, associated with a concomitant over-expression of the efflux transporter P-
glycoprotein (Abcb1) (Fardel et al., 1993; Jigorel et al., 2005; Luttringer et al., 2002). By 
contrast, sandwich-cultured rat hepatocytes exhibit functional canalicular networks (LeCluyse 
et al., 1994; Liu et al., 1999b), even if they also display reduced expression of sinusoidal 
influx transporters with time in culture when compared to freshly isolated hepatocytes (Borlak 
and Klutcka, 2004; Kotani et al., 2011; Tchaparian et al., 2011). With regard to human 
hepatocytes cultured either in monolayer or sandwich conditions, expression of drug 
transporters appears to be much better preserved with time in culture when compared to rat 
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counterparts (Hoffmaster et al., 2004; Jigorel et al., 2005; Kotani et al., 2011; Li et al., 2009; 
Schaefer et al., 2012; Takeba et al., 2011). 
Unlike primary rat and human hepatocytes, cultured mouse hepatocytes remain poorly 
characterized with respect to drug transporter expression and activity, even if bile acid 
transport and multidrug resistance-associated protein (Mrp/Abcc) 4 expression have been 
recently investigated in sandwich-cultured mouse hepatocytes (Swift and Brouwer, 2010). 
Primary mouse hepatocytes likely represent an interesting in vitro model for studying liver 
drug transporters, because they can originate from various and already generated knockout 
mice in which specific liver transporter has been deleted, thus potentially allowing to address 
the function and the substrates of the disrupted transporter (Klaassen and Lu, 2008). Primary 
mouse hepatocytes may also served for identifying signalling ways governing transporter 
expression, through, for example, the use of hepatocytes from transgenic mice deficient in 
drug-sensing receptors such as pregnane X receptor (PXR), aryl hydrocarbon receptor (AhR) 
or constitutive androstane receptor (CAR), known to be involved in transporter regulation 
(Klaassen and Aleksunes, 2010). Before considering the use of primary hepatocytes from 
transgenic mice for transporter studies, accurate characterization of basal transporter 
expression in primary wild-type mouse hepatocytes is however required. The present study 
was therefore designed to carefully analyze expression, activity and regulation of drug 
transporters in mouse hepatocytes cultured in monolayer or sandwich configurations; the 
transporters studied in this work correspond to referent hepatic SLC and ABC transporters 
(Funk, 2008) and their cellular localization  is indicated in Fig. 1. 
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2. Materials and methods 
2.1. Chemicals  
Rhodamine 123, probenecid, verapamil, phenobarbital and dexamethasone were purchased 
from Sigma-Aldrich (Saint-Quentin Fallavier, France), whereas carboxy-2,7-
dichlorofluoresceine (CF) diacetate and 2,3,7,8-tetrachlorodibenzo-p-dioxine (TCDD) were 
provided by Invitrogen/Life Technologies (Villebon sur Yvette, France) and Cambridge 
Isotope Laboratories (Andover, MA), respectively. [3H(G)] taurocholic acid (sp. act. 1.19 
Ci/mmol), [6, 7-3H(N)] estrone-3-sulfate (E3S) (sp. act. 57.3 Ci/mmol), [1-14C] tetra-
ethylammonium (TEA) (sp. act. 2.4 mCi/mmol), p-[glycyl-L-3H] aminohippuric acid (PAH) 
(sp. act. 4.53 Ci/mmol ) and [6.7-3H(N)] estradiol 17β-D glucuronide (sp. act. 41.8 Ci/mmol) 
were from Perkin-Elmer (Boston, MA). All other chemicals were commercial products of the 
highest purity available. 
 
2.2. Hepatocyte isolation and culture 
Hepatocytes from adult female C57BL/6 mice weighing around 20 g were isolated by 
perfusion of the liver with a highly active LiberaseTM solution (Roche, Meylan, France), as 
previously described (Fardel et al., 1993). They were then finally suspended in Williams’E  
medium supplemented with 5 µg/mL insulin, 2 mM glutamine, 10 IU/mL penicillin, 10 
µg/mL streptomycin and 10 % (vol/vol) fetal calf serum and immediately seeded on 24-well 
plastic plates either uncoated or coated with collagen type I (BD Biosciences, Le Pont de 
Claix, France); the cell density (200000 cells/well) used for seeding has been previously 
shown to be in the range of optimal ones for culturing mouse hepatocytes (Swift and Brouwer, 
2010). Seeding medium was removed after a 4 h-period and replaced by a similar Williams’ E 
medium, except that fetal calf serum was withdrawn and 1 mg/ml bovine serum albumin and 
0.1 µM dexamethasone were added. This medium was then changed daily. For sandwich-
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configuration primary cultures, collagen-plated hepatocytes were overlaid within 24 h after 
cell plating with 0.25 mg/ml ice-cold Matrigel (BD Biosciences), as previously described 
(Annaert et al., 2001). For transporter regulation studies, mouse hepatocytes were daily 
treated (starting from 4 h after cell seeding) for three days with 10 nM TCDD, 3.2 mM 
phenobarbital or 10 µM dexamethasone. All protocols were in accordance with the French 
laws and the institution’s guidelines for animal welfare. 
 
2.3. RNA isolation and RT-qPCR analysis 
Total RNA was isolated from cells using the TRIzol reagent (Invitrogen/life Technologies). 
RNA was then subjected to reverse transcription-quantitative polymerase chain reaction (RT-
qPCR), using the fluorescent dye SYBR Green methodology, specific gene primers (listed in 
Supplementary Table 1) and an ABI Prism 7300 detector (Applied Biosystem, Foster City, 
CA, USA), as previously described (Le Vee et al., 2008). Quantification of the steady-stage 
target mRNA levels of these genes was calculated after normalization of the total amount of 
cDNA tested to a 18S RNA endogenous reference, as previously described (Moreau et al., 
2011). Data were usually expressed in % of mRNA levels found in freshly isolated 
hepatocytes or in untreated control hepatocytes, arbitrarily set at 100 %. 
 
2.4. Western-blot analysis 
Total cellular extracts were prepared as previously described (Lecureur et al., 2005). Proteins 
(40 µg) were then separated on polyacrylamide gels and electrophoretically transferred to 
nitrocellulose membranes. After blocking in Tris-buffered saline containing 4% bovine serum 
albumin, membranes were incubated overnight at 4°C with rat monoclonal antibody M4I-10 
directed against Mrp4 (Abcam, Paris, France) or rabbit polyclonal antibodies against bile salt 
export pump (Bsep/Abcb11) (Cao et al., 2001) or sodium-taurocholate cotransporting 
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polypeptide (Ntcp/Slc10a1) (Kullak-Ublick et al., 1997). After incubation with horseradish 
peroxydase-conjugated secondary antibody, signals were detected by chemiluminescence.  
Gel loading and transfer was checked up through immunolabelling with primary antibody 
against the heat-shock protein HCS70 (Santa Cruz Technology, Heidelberg, Germany). 
 
2.5. Light and fluorescence microscopy. 
Light microscopy and CF fluorescence were employed to monitor the presence of functional 
canalicular networks in cultured hepatocytes, as previously described (Chandra et al., 2001). 
For light microscopy studies, primary hepatocytes were observed using an Axiovert 
microscope (Zeiss, Le Pecq, France). For fluorescence studies, primary hepatocytes were 
incubated with 3 µM CF diacetate for 10 min at 37°C; cells were then washed with ice-cold 
phosphate-buffered saline and visualized using a Leica DM IRB microscope (Leica 
Microsystems, Wetzlar, Germany) equipped with a black/white CoolSNAP ES camera (Roper 
Scientific, Planegg/Martinsried, Germany). Pictures were processed using the Metaview 
software. 
 
2.6. Drug transport assays. 
2.6.1 Sinusoidal influx assay. 
Uptake transport activities due to the sinusoidal transporters Ntcp, organic anion transport 
polypeptides (Oatps/Slcos), organic cation transporter 1 (Oct1/Slc22a1) and anion organic 
transporter 2 (Oat2/Slc22a7) were analyzed through measuring, sodium-dependent-
intracellular accumulation of the Ntcp substrate taurocholate, probenecid-sensitive uptake of 
the Oatp substrate E3S, verapamil-sensitive uptake of the Oct1 substrate TEA and 
probenecid-sensitive uptake of the Oat2 substrate, using a defined transport assay medium 
consisting of 5.3 mM KCl, 1.1 mM KH2PO4, 0.8 mM MgSO4, 1.8 mM CaCl2, 11 mM D-
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glucose, 10 mM HEPES, and 136 mM N-methyl glucamine (Na+-free buffer) or 136 mM 
NaCl (standard buffer), as previously described (Jigorel et al., 2005). Briefly, cells were 
incubated at 37 °C for 5 min in the transport medium supplemented with 43.4 nM [3H] 
taurocholate in the presence or absence of sodium, 3.4 nM [3H] E3S in the presence or 
absence of the Oatp inhibitor probenecid (2 mM), 40 µM [14C] TEA in the presence or 
absence of the Oct1 inhibitor verapamil (50 µM) or 200 nM [3H] PAH in the presence or 
absence of the Oat2 inhibitor probenecid (10 mM). After washing in phosphate-buffered 
saline, cells were lyzed and accumulation of radiolabeled substrates was determined through 
scintillation counting. Taurocholate accumulation values in the presence of sodium minus 
accumulation values in the absence of sodium, E3S uptake values in the absence of 
probenecid minus uptake values in the presence of probenecid, TEA uptake values in the 
absence of verapamil minus uptake values in the presence of verapamil and PAH uptake 
values in the absence of probenecid minus uptake values in the presence of probenecid are 
thought to represent Ntcp-, Oatps-, Oct1- and Oat2-related transport activities (Jigorel et al., 
2005). 
 
2.6.2 Canalicular secretion assay. 
Biliary secretion of drugs was analyzed through determination of drug accumulation into bile 
canaliculi-like structures as previously reported (Annaert et al., 2001; Turncliff et al., 2006). 
Briefly, primary hepatocytes were first incubated for 10 min at 37°C with transport assay 
buffer containing Ca2+ described above or with the same buffer, except that 1.8 mM CaCl2 
was withdrawed and 100 µM EGTA was added, knowing that incubation with this Ca2+-free 
buffer promotes disruption of tight junctions and opening of bile canaliculi networks. Buffers 
were then removed and hepatocytes were further incubated for 10 min at 37°C in transport 
assay medium containing 43.4 nM [3H] taurocholate, 20 nM [3H] estradiol 17β-D 
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glucuronide, 5.25 µM rhodamine 123 or 3 µM CF diacetate. After washing with ice-cold 
phosphate-buffered saline, accumulations of taurocholate, estradiol 17β-D glucuronide and 
rhodamine 123 into cells + bile canaliculi (Ca2+-containing conditions) and into cells only 
(Ca2+-free conditions) were determined by scintillation counting or spectrofluorimetry using a 
SpectraMax Gemini SX spectrofluorometer (Molecular Devices, Sunnyvale, CA) (excitation 
and emission wavelengths were 485 and 535 nm, respectively). Accumulation of CF into cells 
+ bile canaliculi (Ca2+-containing conditions) and into cells only (Ca2+-free conditions) was 
analyzed after an additional 20-min incubation efflux period in CFA-free medium using 
spectrofluorimetry as described above. Biliary excretion index (BEI) was finally calculated 
using the following equation (Liu et al., 1999a): 
 
 
2.6.3. Sinusoidal efflux assay. 
Sinusoidal efflux of CF, a know referent substrate for Mrps, including the sinusoidal 
transporter Mrp3 (Abcc3) (Zamek-Gliszczynski et al., 2003), was investigated through 
determining probenecid-inhibited efflux of the dye from sandwich-cultured hepatocytes 
exhibiting intact bile canaliculi. Briefly, cells were first incubated for 10 min at 37°C with 
transport assay buffer containing Ca2+ described above and supplemented with 3 µM CF 
diacetate. After washing, cells were re-incubated in CF diacetate-free medium for 20 min at 
37°C in the absence or presence of 2 mM probenecid, a well-known inhibitor of Mrps (Payen 
et al., 2000). Retention of CF into cells + bile canaliculi in the presence or absence of 
probenecid was then determined by spectrofluorimetry as described above, allowing to 
Accumulation (Cells+Bile canaliculi)
BEI= 
Accumulation (Cells+Bile canaliculi) – Accumulation (Cells)
X 100
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determine the amount of CF secreted at sinusoidal pole of cells in a probenecid-inhibitable 
manner. Sinusoidal excretion index (SEI) was finally calculated using the following equation: 
 
 
2.7. Statistical analysis 
Quantitative data were usually expressed as means + SD. They were statistically analyzed 
using ANOVA followed by Student-Newman-Keuls or Dunnett post-hoc test, paired 
Student’s t-test or nonparametric Spearman's rank correlation method. The criterion of 
significance was p < 0.05.   
 
3. Results 
3.1. Morphology and canalicular network formation. 
Primary mouse hepatocytes maintained for 3 or 4 days after seeding either in monolayer on 
plastic or collagen or in sandwich configuration with collagen and matrigel formed confluent 
or nearly-confluent cultures (Fig. 2A). Hepatocytes cultured in monolayer exhibited a 
morphology rather flattener than that of sandwich-cultured counterparts, in agreement with 
previous data (Richert et al., 2002). Sandwich-cultured hepatocytes, but not monolayer-
cultured counterparts, displayed extensive canalicular networks (Fig. 2A). These bile 
canaliculi-like structures were moreover fully functional since they strongly accumulated the 
fluorescent dye CF (Fig. 2B). 
 
3.2. Expression of drug transporter mRNAs. 
Expressions of SLC drug transporter mRNAs in primary mouse hepatocytes were lower than 
those found in freshly isolated hepatocytes, whatever the culture time or the culture conditions 
Accumulation (Cells+Bile canaliculi+Probenecid)
SEI= 
Accumulation (Cells+Bile canaliculi+Probenecid) – Accumulation (Cells+Bile Canaliculi)
X 100
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(Fig. 3). SLC transporter mRNA levels found in cultured hepatocytes after the 4-h seeding 
period were thus reduced to approximately 50 % of the values found in freshly isolated 
counterparts and more significantly fall in day 1-cultured hepatocytes (Fig. 3). Expression of 
Ntcp, Oatp1b2 (Slco1b2), Oct1, Oat2 and multidrug and toxin extrusion transporter (Mate) 1 
(Slc47a1) remained thereafter very low along the culture period (from day 1 to day 4 after 
seeding), whatever the culture conditions. By contrast, mRNA expression levels of Oatp1a1 
(Slco1a1) and Oatp1a4 (Slco1a4) significantly raised up for the period day 2-day 4 of culture 
when compared to those found in day 1-cultured hepatocytes, without however significant 
differences between the different culture conditions and without reaching initial value found 
in freshly isolated hepatocytes (Fig. 3).  
 With regard to ABC transporters, bile salt export pump (Bsep/Abcb11) and Mrp6 
(Abcc6) exhibited a time-dependent mRNA expression profile in cultured hepatocytes similar 
to that described above for some of SLC transporters, i.e., an early down-regulation not 
influenced by culture conditions  (Fig. 4). By contrast, Mrp2 (Abcc2) mRNA expression 
remained rather stable during culture (Fig. 4). Other ABC transporters such as multidrug 
resistance (Mdr) 1a (Abcb1a)/P-glycoprotein, Mdr1b (Abcb1b)/P-glycoprotein, Mrp1 
(Abcc1), Mrp4, Mrp5 (Abcc5) and breast cancer resistance protein (Bcrp/Abcg2) exhibited a 
marked up-regulation of mRNA expression with time in culture, in all of the culture 
conditions tested. Three days-old sandwich-cultured hepatocytes displayed however rather 
lower levels of induction of these transporters when compared to their counterparts cultured in 
monolayer/plastic or monolayer/collagen configuration (Fig. 4). Mrp3 (Abcc3) mRNA 
expression was also induced with culture time for the three used culture conditions, even if 
this up-regulation reached a significant level only for 2 days- and 4 days-old hepatocytes 
maintained in monolayer/plastic conditions (Fig. 4).    
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 To more completely analyze the effects of culture time on drug transporter expression, 
drug transporters were ranked from the most expressed to the less expressed according to 
mRNA level of expression and mRNA expression profiles were then compared. As shown in 
Fig. 5, expression profile of drug transporters in freshly isolated hepatocytes is correlated with 
that of 4-h cultured hepatocytes, but not with that of 4 days-old hepatocytes, whatever the 
used culture conditions. By contrast, mRNA expression profiles of 4 days-old hepatocytes 
cultured in monolayer/plastic, monolayer/collagen or sandwich/matrigel conditions were 
highly correlated (Fig. 5). 
 
3.3. Expression of drug transporter proteins. 
To investigate whether some of the alterations of drug transporter mRNA expression reported 
above in cultured mouse hepatocytes parallel changes in transporter protein expression, we 
analyzed protein levels of Ntcp, Bsep and Mrp4 by Western-blotting. As indicated in Fig. 6, 
expressions of Ntcp and Bsep were similar in freshly isolated hepatocytes and 4-h cultured 
hepatocytes, but strongly and similarly reduced in 3 days-old hepatocytes cultured either in 
monolayer/plastic, monolayer/collagen or sandwich/matrigel conditions. By contrast, Mrp4 
protein was not detected in freshly isolated hepatocytes and 4 h-cultured hepatocytes, but was 
strongly induced in 3 days-old hepatocytes cultured in monolayer conditions; it was also up-
regulated  in sandwich-cultured hepatocytes, but to a much lesser extent (Fig. 6), likely 
reflecting the lower induction of Mrp4 mRNAs in this culture configuration (Fig. 3). 
 
3.4. Activity of drug transporters. 
Activity of sinusoidal uptake transporter was first investigated in 4-h cultured hepatocytes. As 
shown in Fig. 7A, intracellular accumulations of the Ntcp substrate taurocholate, of the Oatp 
substrate E3S or of the Oct1 substrate TEA were strongly inhibited by withdrawal of sodium 
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(inhibition by a 5.5-fold-factor) or addition of the Oatp inhibitor probenecid or of the Oct1 
inhibitor verapamil (inhibition by a 7.1- and a 3.7-fold factor, respectively), demonstrating 
that these 4-h cultured hepatocytes exhibited robust Ntcp, Oatp and Oct1 activity. By contrast, 
intracellular accumulation of the Oat2 substrate PAH was only slightly inhibited by the Oat2 
inhibitor probenecid (by a 1.3-fold factor) (Fig. 7A), suggesting that Oat2 activity was rather 
low in 4 h-cultured hepatocytes. Ntcp, Oatp and Oct1 activity in primary hepatocytes were 
next found to be markedly down-regulated with time in culture, whatever the culture 
conditions (Fig. 7B); 3 days-old hepatocytes cultured in a sandwich/matrigel configuration 
displayed however higher Ntcp and Oct1 activities than their counterparts maintained in 
monolayer/plastic or monolayer/collagen conditions, but these differences did not reach a 
significant level (Fig. 7B). 
 Secretion of drugs into bile canaliculi-like structures was studied using Ca2+ 
withdrawal-mediated disruption of canaliculi, as previously described (Liu et al., 1999a). Four 
days-old sandwich-cultured hepatocytes pre-incubated in Ca2+-free conditions exhibited 
decreased retention of taurocholate, in contrast to counterparts maintained in 
monolayer/collagen conditions (Fig. 8A). These data confirmed that sandwich-cultured  
hepatocytes display functional bile canaliculi, in agreement with Fig. 1B, thus permitting the 
calculation of the BEI for taurocholate (Fig. 8A). Decreased accumulation of estradiol-17β-
glucuronide (BEI=16 %), rhodamine 123 (BEI=17%) or CF (BEI=22 %) were also found in 
sandwich-cultured hepatocytes pre-incubated in Ca2+-free medium (Fig. 8B). Sandwich-
cultured hepatocytes with intact bile canaliculi were finally found to exhibit increased total 
accumulation of CF in the presence of the Mrp inhibitor probenecid, likely reflecting a 
probenecid-inhibited sinusoidal efflux of the fluorescent dye, with a SEI value of 29 % (Fig. 
8C). 
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3.5. Regulation of drug transporter mRNA expression by prototypical activators of drug 
sensing receptors. 
To determine whether primary mouse hepatocytes may express signaling ways involved in 
transporter regulation, cultured hepatocytes were exposed to prototypical ligands of drug 
sensing receptors and mRNA expressions of various transporters were analyzed (Fig. 9). The 
PXR activator dexamethasone (Moore et al., 2000) induced expression of Oatp1a4, Mrp2 and 
Mrp4; TCDD, a potent agonist of AhR (Hankinson, 1995), increased expression of Mrp4. 
Phenobarbital, which activates the CAR signaling cascade (Masahiko and Honkakoski, 2000), 
enhanced expression of Ntcp, Oatp1a4, Bsep and Mrp2. These inductions were observed in 
hepatocytes cultured in monolayer/plastic, monolayer/collagen or sandwich/matrigel 
configurations (Fig. 9). However the level of induction was somewhat different according to 
the culture conditions. Indeed, Oatp1a4 was rather less induced in dexamethasone- or 
phenobarbital-treated hepatocytes maintained in sandwich configuration, than in monolayer-
cultured counterparts, whereas Mrp4 induction by dexamethasone reached a significant level 
only in hepatocytes cultured in sandwich/matrigel configuration (Fig. 9). 
 
 
Discussion 
The present study demonstrated that expression of drug transporters in primary mouse 
hepatocytes is markedly influenced by time in culture, whatever the culture conditions used, 
i.e., monolayer/plastic, monolayer/collagen or sandwich/matrigel configurations. Indeed, 
mRNA expression of SLC transporters, especially those of Ntcp, Oatp1b2, Oct1, Oat2 and 
Mate1, rapidly and remarkably fall during primary culture. This is associated with a 
concomitant loss of Ntcp protein expression and a reduction of Ntcp, Oatp and Oct1 transport 
activities. Expression of ABC transporters is also markedly impaired, but mostly in an 
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opposite manner. Indeed, various ABC transporters, such as Mdr1a, Mdr1b, Mrp1, Mrp3, 
Mrp4 and Bcrp, display a marked increase of mRNA expression (and protein expression for 
Mrp4) with time in culture, whatever the culture conditions used. By contrast, the bile salt 
canalicular transporter Bsep is down-regulated at both mRNA and protein level with time in 
culture. Only Mrp2 mRNA expression appears to be not significantly changed during primary 
culture of mouse hepatocytes. When considering transporter expression profiles, those found 
in 4 days-old hepatocytes cultured in monolayer/plastic, monolayer/collagen or 
sandwich/matrigel configurations fail to correlate with that of freshly isolated hepatocytes, but 
correlate each over. The use of sandwich versus monolayer configurations does not therefore 
prevent major changes in transporter expression occurring in primary mouse hepatocytes. 
Similarly, the use of sandwich cultures did not counteract reduction of sinusoidal SLC 
transporter expression in primary rat hepatocytes (Borlak and Klutcka, 2004; Kotani et al., 
2011; Tchaparian et al., 2011), whereas, by contrast, SLC transporter expression is rather 
better preserved in primary human hepatocytes (Jigorel et al., 2005).    
 If the culture conditions do not influence overall transporter expression profile in 
primary mouse hepatocytes, some differences between monolayer and sandwich 
configurations have however to be underlined. First, 3 days-old sandwich-cultured 
hepatocytes display rather limited mRNA up-regulation of the ABC transporters Mdr1b, 
Mrp1, Mrp4, Mrp5 and Bcrp when compared to their counterparts cultured in monolayer 
configurations, indicating that the sandwich configuration may transiently limit culture-
associated over-expression of some ABC transporters. Secondly and probably most 
importantly, sandwich-cultured mouse hepatocytes exhibit functional bile canaliculi, which, 
by contrast, were not present in mouse hepatocytes cultured in monolayer configurations. 
Canalicular secretion of the bile salt taurocholate has been consequently detected only in 
sandwich-cultured mouse hepatocytes. BEI calculated for taurocholate in our sandwich-
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cultured mouse hepatocytes was 36%, which is very similar to the value previously reported 
in sandwich-cultured mouse hepatocytes by Swift and Brouwer (Swift and Brouwer, 2010). 
For17-β-estradiol glucuronide, CF and rhodamine 123, BEI values calculated from our data 
are around 15-20 % and therefore lower than that found for taurocholate. Similarly, BEI 
values reported for CF (28 %) and rhodamine 123 (8 %) in sandwich/matrigel-cultured rat 
hepatocytes are lower than that calculated for taurocholate (60 %) (Turncliff et al., 2006). 
Interestingly, polarization of sandwich-cultured mouse hepatocytes allowed us to detect 
probenecid-inhibited sinusoidal efflux of CF, likely reflecting the activity of sinusoidal Mrps, 
and especially Mrp3, known to handle CF (Zamek-Gliszczynski et al., 2003) .  
 The precise cellular and molecular mechanisms involved in transporter expression 
changes occurring in primary mouse hepatocytes remain to be determined. A link with the de-
differentiation process, which commonly occurs in primary rodent hepatocytes (Olsavsky 
Goyak et al., 2010), has most likely to be considered. This in vitro down-regulation of liver-
specific functions is thought to result from the disruption of the normal tissue architecture, as 
well as from adaptation to in vitro environment (Elaut et al., 2006) and the subsequent loss of 
liver-enriched transcription factors such as C/EBPα and hepatocyte nuclear factors (HNFs) 
(Olsavsky Goyak et al., 2010), that directly or indirectly control drug transporter expression 
(Geier et al., 2008; Li and Klaassen, 2004). In addition, hepatocyte isolation process and 
primary culture are associated with production of oxygen reactive-species, which may 
contribute to transporter regulation (Ziemann et al., 1999). Interestingly, contact between 
hepatocytes and extracellular matrix proteins as well as the maintenance of a tridimensional 
morphology have been postulated to play a key-role in the maintenance of a well-
differentiated state for hepatocytes (Schuetz et al., 1988) and thus likely contribute to the 
polarized status of mouse sandwich-cultured hepatocytes. Such cells nevertheless exhibit 
major changes in transporter expression levels, indicating that the use of a sandwich/matrigel 
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it is not sufficient to keep a full differentiated status. The global profile of transporter 
expression changes in primary mouse hepatocytes, i.e. down-regulation of sinusoidal SLC 
transporters and up-regulation of most of ABC transporters, may be in fact closed to a 
cholestatic expression pattern, as already hypothesized for cultured rat hepatocytes (Rippin et 
al., 2001). It may reflect an adaptative protective response for hepatocytes, resulting in 
decreased accumulation of drugs and chemical toxins through reduced uptake and increased 
efflux.  
 Primary mouse hepatocytes were found to retain major signaling ways regulating drug 
transporter expression in response to chemical inducers, whatever the culture conditions used. 
Indeed, Mrp4, a well-known target for AhR (Xu et al., 2010), was up-regulated in TCDD-
treated primary mouse hepatocytes. Similarly, expression of the PXR targets Mrp2 and 
Oatp1a4 (Cheng et al., 2005; Kast et al., 2002) were induced in cultured mouse hepatocytes 
exposed to the PXR agonist dexamethasone, whereas phenobarbital treatment increased 
expression of Mrp2 and Mrp4, knowing that these ABC transporters have been previously 
shown to be regulated by CAR (Assem et al., 2004; Kast et al., 2002; Maher et al., 2005). 
Phenobarbital also induced expression of the SLC transporters Oatp1a4 and Ntcp and of the 
ABC transporter Bsep in primary mouse hepatocytes. These transporters have however not 
been previously reported to constitute targets for CAR (Wagner et al., 2005), thus suggesting 
the implication of CAR-independent effects of phenobarbital, possibly related to induction of 
HNF-4α by the barbiturate (Bell and Michalopoulos, 2006).  
 Data from our present study indicate that primary mouse hepatocytes can be used for 
drug transporter studies, with however the necessity to respect adequate culture conditions for 
that. Short time-cultured hepatocytes on plastic dishes, i.e. 4-h old primary hepatocytes, are 
likely to be retained for investigating whether a xenobiotic can be handled, or can inhibit a 
sinusoidal hepatic influx drug transporter, owing to the high transporter activities displayed by 
18 
 
these cells. Only Oat2-mediated PAH uptake was low in such cells, thus supporting the need 
to test additional Oat2 substrates or culture conditions to better characterize Oat2 transport in 
cultured mouse hepatocytes. For the study of canalicular and sinusoidal efflux transporter 
activities, the use of sandwich-cultured hepatocytes is the unique choice since polarity was 
retained only for this culture configuration; the marked altered profile of drug transporter 
expression in sandwich-cultured mouse hepatocytes has however to be kept in mind when 
interpreting experimental data and further studies are likely required to precise the exact 
relevance of in vitro data generated with primary mouse hepatocytes to in vivo situations. 
Finally, primary mouse hepatocytes can also be used for transporter regulation studies, 
whatever the culture conditions.  
 In summary, functional expression and regulation of drug transporters have been 
characterized in primary mouse hepatocytes, demonstrating the feasibility of using such cells 
for investigating interactions of xenobiotics with hepatic transporter activity or regulation. 
Such studies could be especially interesting to perform with primary hepatocytes from wild-
type and transporter- or drug sensing receptor-deficient knockout mice, in order to investigate 
the implication of the deleted gene in term of drug transporter activity or regulation.  
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Legends to figures 
 
Fig. 1. Schematic representation of drug transporter expression in mouse hepatocyte. 
 
Fig 2. Cell morphology and formation of functional canalicular networks in primary mouse 
hepatocytes.  
Primary mouse hepatocytes were cultured in monolayer/plastic, monolayer/collagen and 
sandwich/matrigel configurations for 3 and 4 days. Hepatocyte morphology was then 
examined by light microscopy (A) whereas functional bile canaliculi were detected through 
CF labeling (B), as described in Materials and Methods. Bile canaliculi are indicated by 
arrows. Bar = 25 µM.  
 
Fig. 3. Expression of SLC transporter mRNAs in primary mouse hepatocytes.  
Primary mouse hepatocytes were cultured in monolayer/plastic, monolayer/collagen or 
sandwich/matrigel configurations for various lengths of time after seeding (from 4 h to 4 
days). SLC transporter mRNA expressions were then determined by RT-qPCR, as described 
in Materials and Methods. Data are expressed for each transporter as percentage of expression 
found in freshly isolated mouse hepatocytes (FIH), arbitrarily set at the value of 100 %; they 
are the means + SEM of values from at least three independent assays. *, p<0.05 when 
compared to FIH; #, p<0.05 when compared to 4 h-old cultured hepatocytes. D, day. 
 
Fig. 4. Expression of ABC transporter mRNAs in primary mouse hepatocytes.  
Primary mouse hepatocytes were cultured in monolayer/plastic, monolayer/collagen or 
sandwich/matrigel configurations for various lengths of time after seeding (from 4 h to 4 
days). ABC transporter mRNA expressions were then determined by RT-qPCR, as described 
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in Materials and Methods. Data are expressed for each transporter as percentage of expression 
found in freshly isolated mouse hepatocytes (FIH), arbitrarily set at the value of 100 %; they 
are the means + SEM of values from at least three independent assays. *, p<0.05 when 
compared to FIH; #, p<0.05 when compared to 4 h-old cultured hepatocytes. D, day. 
 
Fig. 5. Correlation between drug transporter mRNA expression profiles in freshly isolated 
mouse hepatocytes and primary mouse hepatocytes.  
Drug transporters were ranked according to their level of mRNA expression in freshly 
isolated mouse hepatocytes (FIH), 4 h-old cultured hepatocytes and 4 days-old hepatocytes 
cultured in monolayer/plastic, monolayer/collagen or sandwich/matrigel configurations. 
Correlations between transporter expression profiles were next analyzed using the Spearman's 
rank correlation method. Spearman's rank coefficients (ρ), p values and equations for the 
regression lines are provided at bottom right of each correlation graph. 
 
Fig. 6. Ntcp, Bsep and Mrp4 protein expression in primary mouse hepatocytes. 
Total protein extracts were prepared from freshly isolated mouse hepatocytes (FIH) and from 
primary mouse hepatocytes cultured in monolayer/plastic, monolayer/collagen or 
sandwich/matrigel configurations for various lengths of time after seeding (4 h, 1 or 3 days). 
Transporter protein expression was then analyzed by Western-blotting. Data shown are 
representative of two independent experiments.  
 
Fig. 7. Sinusoidal drug influx activities in primary mouse hepatocytes. 
(A) Primary mouse hepatocytes were cultured in monolayer/plastic configuration for 4 h after 
seeding. Cells were then incubated with the Ntcp substrate taurocholate (43.4 nM), the Oct1 
substrate TEA (40 µM), the Oatp substrate E3S (3.4 nM) or the Oat2 substrate PAH (200 nM) 
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for 5 min, in the presence or absence of sodium (for taurocholate), 50 µM verapamil (for 
TEA), 2 mM probenecid (Prob) (for estrone-3-sulfate) or 10 mM probenecid (for PAH). 
Intracellular accumulations of substrates were then determined by scintillation counting. Data 
are the means + SEM of at least three independent experiments. *; p<0.05 when compared to 
uptake in the presence of sodium (for taurocholate) or in the absence of inhibitors (for TEA, 
E3S and PAH). (B)  Primary mouse hepatocytes were cultured in monolayer/plastic, 
monolayer/collagen or sandwich/matrigel configurations for various lengths of time after 
seeding (from 4 h to 4 days). Sodium-dependent accumulation of taurocholate (Ntcp activity), 
verapamil-inhibitable accumulation of TEA (Oct1 activity) and probenecid-inhibitable uptake 
of E3S (Oatp activity) were then determined as described above. Data are the means + SEM 
of three independent assays.  *, p<0.05 when compared to 4 h-old cultured hepatocytes. D, 
day. 
 
Fig. 8. Canalicular (A, B) and sinusoidal (C) drug efflux activities in primary mouse 
hepatocytes. 
(A) Primary mouse hepatocytes were cultured in monolayer/collagen or sandwich/matrigel 
configurations for 4 days after seeding. Cells were then pre-incubated in the presence or 
absence of Ca2+ for 10 min, and next incubated with taurocholate for 10 min. Intracellular 
accumulations of taurocholate in cells + bile canaliculi (condition with Ca2+) or in cells only 
(condition without Ca2+) were next determined by scintillation counting. Data are the means + 
SEM of five independent experiments. *, p<0.05 when compared to cells pre-incubated in the 
presence of Ca2+. BEI for taurocholate, calculated as described in Materials and Methods, is 
indicated on the top of the graph. (B)  4 days-old sandwich-cultured mouse hepatocytes were 
pre-incubated in the presence or absence of Ca2+ for 10 min and intracellular accumulations of 
estradiol-17β glucuronide, rhodamine 123 and CF in cells + bile canaliculi (condition with 
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Ca2+) or in cells only (condition without Ca2+) were then determined as described in Materials 
and Methods. Data are the means + SEM of at least three independent experiments. *, p<0.05 
when compared to cells pre-incubated in the presence of Ca2+. BEI calculated as described in 
Materials and Methods are indicated on the top of the graphs. (C) 4 days-old sandwich-
cultured mouse hepatocytes were loaded with CF diacetate for 10 min at 37°C in the presence 
of Ca2+. Hepatocytes were next incubated in CF diacetate-free medium for 20 min in the 
absence or presence of 2 mM probenecid (Prob). CF retention into cells + bile canaliculi was 
then determined by spectrofluorimetry. The data are the means + SEM of five independent 
experiments. *, p<0.05 when compared to cells not exposed to probenecid. SEI for CF, 
calculated as described in Materials and Methods, is indicated on the top of the graph. FAU, 
fluorescence arbitrary unit. 
 
Fig. 9. Regulation of drug transporter expression by drug-sensing receptor agonists in primary 
mouse hepatocytes.   
Primary mouse hepatocytes, cultured in monolayer/plastic, monolayer/collagen or 
sandwich/matrigel configurations, were either untreated (Unt) or exposed to 10 µM 
dexamethasone (Dex), 10 nM TCDD or 3.2 mM phenobarbital (Pheno) for three days. Drug 
transporter mRNA expressions were then determined by RT-qPCR, as described in Materials 
and Methods. Data are expressed as induction factors, i.e., the ratio transporter mRNA level in 
xenobiotic-treated hepatocytes versus that found in untreated counterpart for each culture 
condition. Data are the means + SEM of five independent experiments. *, p<0.05 when 
compared to control untreated cells.   
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Supplementary Table 1. Primers used for qPCR assays 
___________________________________________________________________________ 
 
Gene           Sense                Antisense  
___________________________________________________________________________ 
  
Ntcp GCTGGTCAGATGAAAGACCT GGAGTTCAGCAAGATCAAGG 
Oatp1a1 TAGCTTGCCTCCAGTATGCCTT ACAGGCCAAATGCTATGTATGC 
Oatp1a4 CAAGCTTTCTCCCTGCACTCTT TCCTTCGCAGTGAGCTTCATT 
Oatp 1b2 AGCAATGATCGGACCAATCCT AACCCAACGAGCATCCTGA  
Oat2 GATCACTGCTCTGGTGGTGA GAGTGCAGTGAATCCCATTCC   
Oct1 TGGCTGGGTGTACGACACTC TCCTGTAGCCAGAGCCGACA     
Mate1 GAATGGGTGGGCCAAGTATG CATTGACCTGTCGTGCTGGAT 
Mdr1a  ATGACAGATAGCTTTGCAAGTGTA GGCAAACATGGCTCTTTTATCG 
Mdr1b AAGCCAGTATTCTGCCAAGCAT CTCCAGACTGCTGTTGCTGATG  
Bsep CCTGTCAGCATTTTTGTCTG TCATCGCCTTCCTCTTTAAC 
Bcrp TGGCTGTCCTGGCTTCAGTAC CCAAGAATTCATTATACTGCAA                 
Mrp1 CGATCAAGAGTGGCGAAGG AGGTGATGCCATTCAGTGTG 
Mrp2 GCTGGGAGAAATGGAGAATGTC ACTGCTGAGGGACGTAGGCTA 
Mrp3 TCCCACTTTTCGGAGACAGTAAC CTGAGGACCTTGAAGTCTTGGA   
Mrp4 TGCTCCTCGTCGTAAGTGTG TGGAGGGAGGACGATAAAT 
Mrp5 GCTCCCTTTTTCCTGTTCACCTGTGC ATGGGGAGGAGCCTTGTTCTTGATTC     
Mrp6 GGATTGACAGCAGAAGAGG GCAGAGGAAGAGGAACAGG 
18S CGCCGCTAGAGGTGAAATTC TTGGCAAATGCTTTCGCTC 
__________________________________________________________________________________________ 
 
 
 
   
